Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Contract duration: until .6 (possible extension) Location: Basel Workload: % Responsibilities: Contribute to the trial protocol development as it relates to biosample management requirements. Translate protocol requirements into laboratory operational planning and set up. Initiate contracts
Our client is an international financial institution with a long?standing mandate to support global monetary and financial stability. Operating with a highly professional, multicultural workforce, the institution provides banking, asset?management, and analytical services to central banks